Advances in treatment of elderly primary central nervous system lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in treatment of elderly primary central nervous system lymphoma

Published:2021-08-26 Issue:3 Volume:196 Page:473-487
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Martinez‐Calle Nicolas¹^ORCID,Isbell Lisa K.²,Cwynarski Kate³,Schorb Elisabeth²^ORCID

Affiliation:

1. Clinical Haematology Department Nottingham University Hospitals NHS Trust Nottingham UK

2. Department of Haematology, Oncology and Stem Cell Transplantation Faculty of Medicine University of Freiburg Freiburg Germany

3. Department of Haematology University College Hospital London UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17799

Reference124 articles.

1. Primary CNS Lymphoma in the Elderly: The Challenge

2. The elderly left behind—changes in survival trends of primary central nervous system lymphoma over the past 4 decades

3. First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysis

4. Challenges in the treatment of elderly patients with primary central nervous system lymphoma

5. The use of frailty assessments in treating older adults with aggressive lymphomas

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial;The Lancet Haematology;2024-03

2. Evidence-based management of primary and secondary CNS lymphoma;Seminars in Hematology;2023-12

3. How I treat secondary CNS involvement by aggressive lymphomas;Blood;2023-11-23

4. Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial;BMC Cancer;2023-08-18

5. A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma;Cancer;2023-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3